drugset / Trial / NCT00610688

Controlled Trial of Prenatal Vitamin D3 Supplementation to Prevent Vitamin D Deficiency in Mothers and Their Infants

NCT00610688 ↗

RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this research study is to compare the effects of higher dose vitamin D with commonly recommended dose in pregnant women to see which is better in achieving and/or maintaining sufficient vitamin D blood levels during pregnancy and in newborn infants as well as improving growth in the infant.

Timeline

Start
2008-01
Primary completion
2011-06
Completion
2012-04

Outcome

Met primary endpoint

paper were significantly higher in the 2000 and 4000 IU than the 400 IU/d group (P < .001) PMID 23559082 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 1600 iu —
Subject Cholecalciferol Other / unclassified 3600 iu —

Indications